NDC 50090-0706

Doxazosin

Doxazosin

Doxazosin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Doxazosin Mesylate.

Product ID50090-0706_071d29ed-d406-4bc5-817d-8e59cb26d8a7
NDC50090-0706
Product TypeHuman Prescription Drug
Proprietary NameDoxazosin
Generic NameDoxazosin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-07-14
Marketing CategoryANDA /
Application NumberANDA075580
Labeler NameA-S Medication Solutions
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-0706-0

30 TABLET in 1 BOTTLE (50090-0706-0)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0706-0 [50090070600]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075580
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-28
Marketing End Date2019-01-31

NDC 50090-0706-1 [50090070601]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075580
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-28
Marketing End Date2019-01-31

Drug Details

NDC Crossover Matching brand name "Doxazosin" or generic name "Doxazosin"

NDCBrand NameGeneric Name
0093-2067DoxazosinDoxazosin Mesylate
0093-2068DoxazosinDoxazosin Mesylate
0093-2069DoxazosinDoxazosin Mesylate
0093-2070DoxazosinDoxazosin Mesylate
0378-4021Doxazosindoxazosin mesylate
0378-4022Doxazosindoxazosin mesylate
0378-4024Doxazosindoxazosin mesylate
0378-4028Doxazosindoxazosin mesylate
0615-5536DoxazosinDoxazosin mesylate
0615-5537DoxazosinDoxazosin mesylate
0615-6570DoxazosinDoxazosin mesylate
0615-6571DoxazosinDoxazosin mesylate
0832-0356DoxazosinDoxazosin Mesylate
0832-0357DoxazosinDoxazosin Mesylate
0832-1358DoxazosinDoxazosin Mesylate
0832-1359DoxazosinDoxazosin Mesylate
68071-1889DoxazosinDoxazosin
68071-4273DoxazosinDoxazosin
68071-3298DoxazosinDoxazosin
68071-3331DoxazosinDoxazosin
68071-3341DoxazosinDoxazosin
68071-4272DoxazosinDoxazosin
68084-862DoxazosinDoxazosin
68084-836DoxazosinDoxazosin
68084-851DoxazosinDoxazosin
68382-783DoxazosinDoxazosin
68382-785DoxazosinDoxazosin
68382-784DoxazosinDoxazosin
68382-786DoxazosinDoxazosin
68645-464DoxazosinDoxazosin
68645-465DoxazosinDoxazosin
68645-463DoxazosinDoxazosin
68788-7149DoxazosinDoxazosin
68788-7328DoxazosinDoxazosin
68788-9675DoxazosinDoxazosin
70518-0839DoxazosinDoxazosin
70518-1061DoxazosinDoxazosin
70518-1645DoxazosinDoxazosin
70518-1560DoxazosinDoxazosin
70518-1804DoxazosinDoxazosin
70771-1115DoxazosinDoxazosin
70771-1114DoxazosinDoxazosin
70771-1112DoxazosinDoxazosin
70771-1113DoxazosinDoxazosin
71335-0309DoxazosinDoxazosin
71335-0349DoxazosinDoxazosin
71335-0002DoxazosinDoxazosin
71610-153DoxazosinDoxazosin
71610-160DoxazosinDoxazosin
71610-043DoxazosinDoxazosin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.